Dr. Kamran Shamsa, MD

Dr. Shamsa practices at Ronald Reagan UCLA Medical Center in Los Angeles, California, part of University of California Health.

Dr. Shamsa's NPI, 1902083900, was assigned on January 22, 2008. Dr. Shamsa graduated from UC San Diego School of Medicine in 2004. Dr. Shamsa's California license number on file is A93254.

Dr. Shamsa's primary practice is Ronald Reagan UCLA Medical Center, at 757 Westwood Plaza, Los Angeles, CA 90095 in Los Angeles County. The practice phone is (310) 825-6301.

Dr. Shamsa's primary practice is Ronald Reagan UCLA Medical Center in Los Angeles, California, part of University of California Health. Dr. Shamsa is also affiliated with Cedars-Sinai Medical Center. The medical group on file is UCLA Medical Group. Dmand AI also links Dr. Shamsa to 3 more hospitals, 1 group practice or clinic and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Shamsa practices, 7 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Shamsa's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Shamsa is board certified in cardiovascular disease by the American Board of Internal Medicine. Dr. Shamsa has a license on file in California.

Dmand AI lists aneurysm, atrial fibrillation and flutter, cardiac arrhythmia, cardiomyopathy, cerebrovascular disease, chronic hypertension, circulation problems and coronary artery disease among the conditions Dr. Shamsa treats.

CMS data shows 3,500 Medicare services from Dr. Shamsa across 26 procedure codes in 2024, for 1,250 Medicare patients. Medicare paid $279,473 for them.

CMS counts 1,250 Medicare patients who saw Dr. Shamsa in 2024. The largest group is 65 to 74, with 463 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 35% are also on Medicaid. Their average risk score is 2.28, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Shamsa's median patient age at 65, with 45% women.

In 2024, Dr. Shamsa wrote 5,410 Medicare Part D claims for 688 patients. 83% of them were for generic drugs. CMS names the drug for 5,127 of them, across 59 drugs with 11 or more claims each, at $907,851 in total drug cost. In 2023, CMS named 4,837 claims across 60 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Shamsa for performance year 2024, reported as part of a group. Dr. Shamsa accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Shamsa as offering telehealth.

Dmand AI links 3 papers to Dr. Shamsa, published from 2015 to 2025. Dr. Shamsa's most frequent co-authors are Pouyan Famini, MD, Gregg Curtis Fonarow, MD and Tamara B. Horwich, MD.

CMS Open Payments shows 73 general payments to Dr. Shamsa from 12 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 79% of the total. Astellas Pharma US Inc paid the most, $38,952.

Dmand AI lists 1 award for Dr. Shamsa.

Dr. Shamsa graduated from UC San Diego School of Medicine in 2004. Dr. Shamsa is a member of ACC.

Dr. Shamsa is in network with 12 carriers, including Elevance, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.